Related Experiment Videos
Alpha-2 adrenoceptors modulate [3H]dopamine release from rabbit retina
Summary
Dopamine, norepinephrine, and epinephrine inhibit dopamine release in rabbit retina via alpha-2 adrenoceptors. Dopamine antagonists suggest a tonic dopamine receptor activation, while alpha-2 agonists confirm inhibitory roles.
Area of Science:
- Neuroscience
- Ophthalmology
- Pharmacology
Background:
- Dopamine plays a crucial role in retinal function and neurotransmission.
- The regulation of dopamine release in the retina is complex and involves various receptors.
Purpose of the Study:
- To investigate the role of catecholamines and their receptors in modulating dopamine release in the rabbit retina.
- To identify the specific subtypes of adrenoceptors involved in this regulation.
Main Methods:
- In vitro study using rabbit retina preloaded with [3H]dopamine.
- Field stimulation to evoke calcium-dependent dopamine release.
- Application of various catecholamines, uptake inhibitors (nomifensine), dopamine antagonists (S-sulpiride), and alpha-adrenoceptor agonists/antagonists (clonidine, methoxamine, phentolamine, yohimbine, prazosin).
Main Results:
- Dopamine, norepinephrine, and epinephrine inhibited [3H]dopamine release in a concentration-dependent manner.
- S-sulpiride increased dopamine release, indicating tonic activation by endogenous dopamine.
- Norepinephrine and epinephrine inhibited dopamine release via alpha adrenoceptors, specifically alpha-2 subtype as indicated by clonidine's effect and antagonism by yohimbine.
Conclusions:
- Catecholamines, particularly dopamine, norepinephrine, and epinephrine, exert inhibitory control over dopamine release in the rabbit retina.
- Alpha-2 adrenoceptors are implicated in this inhibitory modulation.
- A tonically active dopaminergic receptor system is present in the rabbit retina.